Option Care Health Inc (OPCH) shares tumbled 5.82% in pre-market trading on Thursday, despite reporting better-than-expected third-quarter results. The sharp decline appears to be driven by the company's full-year 2025 guidance, which fell short of some investor expectations.
For the third quarter ended September 30, 2025, Option Care Health reported revenue of $1.435 billion, up 12.2% year-over-year and surpassing the analyst consensus of $1.412 billion. The company's adjusted earnings per share (EPS) came in at $0.45, beating the estimated $0.42. Adjusted EBITDA for the quarter was $119.5 million, also exceeding the expected $118.4 million.
However, the company's outlook for the full year 2025 seems to have disappointed investors. Option Care Health expects net revenue between $5.60 billion and $5.65 billion, which is in line with the current FactSet estimate of $5.63 billion. The adjusted EPS guidance of $1.68 to $1.72 also aligns with the consensus estimate of $1.71. Despite meeting expectations, the guidance may not have been strong enough to justify the stock's recent valuation, leading to the sell-off. Additionally, the company's projected adjusted EBITDA of $468 million to $473 million for 2025 might have fallen short of some investors' more optimistic projections, contributing to the negative sentiment in pre-market trading.
Comments